Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Oct 23,2015
X-Chromosome Silencing Depends on Antisense RNA
    Think of the silencing of the X chromosome as a construction project. Then, imagine you hear the beeping of heavy machinery operating in reverse. That's the sound of the Xist gene being transcribed in the backwards, or antisense, direction. The Xist gene is read in the forward direction too, otherwise it wouldn't generate a long,Read more
More
Oct 23,2015
Progress of PCSK9 inhibitors displays power of human genetics in finding future therapies
An update on PCSK9 inhibitors presented at the annual Cardiometabolic Health Congress showcased the rapid development of the agents, from gene to antibody, and examined where the field is moving in applying the therapies. "This has been a remarkably short period from discovery to actually having a therapeutic,” Jay Horton, MD, chief of the divisionRead more
More
Oct 22,2015
Hi-Res Structure of Aging and Cancer Enzyme Comes into View
    Years after Elizabeth Blackburn, Ph.D. won the Nobel Prize for her seminal work on the molecular nature of telomeres and co-discovery of the ribonucleoprotein enzyme telomerase, scientists still struggle with fully understanding the intricacies surrounding this inherent genetic mechanism for maintaining genomic stability.  The telomerase enzyme is known to play a significant role in agingRead more
More
Oct 22,2015
CRISPR-Fine Screen of Human Genome Identifies Essential Genes
For the first time, a comprehensive set of cell-essential genes in the human genome has been compiled. This feat, which not only points to deeper studies of human genetics but also suggests a strategy for finding vulnerabilities in cancer cells, was achieved thanks to the CRISPR-Cas9 gene-editing system. This system proved sufficiently rigorous to succeedRead more
More
Oct 21,2015
Protein Found in Malaria Could Help Stop Cancer
    The devastating global effects of malaria have been widely documented, but the presentation of the disease during pregnancy is particular troubling and confounding to researchers. Women living in endemic areas face a much greater risk of contracting malaria when they are pregnant, and associated complications once infected with the parasite. While an average adult residingRead more
More
Protein Found in Malaria Could Help Stop Cancer
Oct 21,2015
FDA Places Advaxis Cancer Immunotherapy on Clinical Hold
    Advaxis announced that the FDA has placed a clinical hold on its experimental immunotherapy axalimogene filolisbac, after the agency received a safety report on the death of a patient treated with the cervical cancer immunotherapy in a clinical study two years ago.  The company noted that the clinical hold will affect four clinical trials ofRead more
More
Oct 20,2015
New Protein Cleanup Factors Found to Control Bacterial Growth
    Biochemists have long known that crucial cell processes depend on a highly regulated cleanup system known as proteolysis, where specialized proteins called proteases degrade damaged or no-longer-needed proteins. They must destroy specific targets without damaging other proteins, but how this orderly destruction works is unknown in many cases. Now researchers report finding how an essentialRead more
More
Oct 20,2015
Editing of Pig DNA May Lead to More Organs for Human
Before pig organs can be made safe for transplantation into human patients, two problems need to be solved. Both problems, ultimately, come down to features of the pig genome. First, the pig genome contains genes that give rise to proteins that the human immune system will not tolerate. Second, it contains retroviruses that could beRead more
More
Oct 19,2015
Immune Gene Prevents Parkinson's Disease
    An estimated seven to ten million people worldwide are living with Parkinson's disease (PD), which is an incurable and progressive disease of the nervous system affecting movement and cognitive function. More than half of PD patients develop progressive disease showing signs of dementia similar to Alzheimer's disease. A research team at University of Copenhagen, Denmark,Read more
More
Immune Gene Prevents Parkinson's Disease
Oct 19,2015
Antioxidant Use May Promote Spread of Cancer
    A team of scientists at the Children's Research Institute at UT Southwestern (CRI) has made a discovery that suggests cancer cells benefit more from antioxidants than normal cells, raising concerns about the use of dietary antioxidants by patients with cancer. The studies were conducted in specialized mice that had been transplanted with melanoma cells fromRead more
More
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->